Compare HYFT & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYFT | DTF |
|---|---|---|
| Founded | 1983 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4M | 80.3M |
| IPO Year | 2017 | N/A |
| Metric | HYFT | DTF |
|---|---|---|
| Price | $2.28 | $11.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 666.7K | 21.1K |
| Earning Date | 12-15-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | ★ $19,019,110.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $51.71 | N/A |
| P/E Ratio | ★ N/A | $24.34 |
| Revenue Growth | ★ 49.46 | N/A |
| 52 Week Low | $0.27 | $10.29 |
| 52 Week High | $3.25 | $11.19 |
| Indicator | HYFT | DTF |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.35 |
| Support Level | N/A | $11.39 |
| Resistance Level | N/A | $11.50 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 53.91 |
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing mainly in a diversified portfolio of investment-grade tax-exempt obligations.